Back to Freestone Grove Partners LP Freestone Grove Partners LP

COGTCOGT

3 quarters

Position history for Freestone Grove Partners LPFreestone Grove Partners LP's holdings in COGENT BIOSCIENCES INC

No. Freestone Grove Partners exited its COGT (Cogent Biosciences) position in Q2 2025. Its Q1 2025 13F listed 16,511 shares worth $98,901. Freestone Grove Partners already held COGT in its Q4 2024 13F, the earliest on record, and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$251,105

Total Shares Change

-32,193

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$7.10
0
2025-Q1
Decreased
16,511
-48.7%
$98,9010.0%$6.48
0
2024-Q4
First report
32,193
—
$251,1050.0%$7.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used